Citation
- Authors: Guo, C., Hildick, K. L., Luo, J., Dearden, L., Wilkinson, K. A., Henley, J. M.
- Year: 2013
- Journal: EMBO J 32 1514-28
- Applications: in vitro / DNA, siRNA, siRNA and DNA cotransfection / INTERFERin, jetPEI, jetPRIME
- Cell types:
- Name: HEK-293
Description: Human embryonic kidney Fibroblast
Known as: HEK293, 293 - Name: HeLa
Description: Human cervix epitheloid carcinoma cells - Name: MEF
Description: Murine embryonic fibroblast cells
- Name: HEK-293
Abstract
Global increases in small ubiquitin-like modifier (SUMO)-2/3 conjugation are a neuroprotective response to severe stress but the mechanisms and specific target proteins that determine cell survival have not been identified. Here, we demonstrate that the SUMO-2/3-specific protease SENP3 is degraded during oxygen/glucose deprivation (OGD), an in vitro model of ischaemia, via a pathway involving the unfolded protein response (UPR) kinase PERK and the lysosomal enzyme cathepsin B. A key target for SENP3-mediated deSUMOylation is the GTPase Drp1, which plays a major role in regulating mitochondrial fission. We show that depletion of SENP3 prolongs Drp1 SUMOylation, which suppresses Drp1-mediated cytochrome c release and caspase-mediated cell death. SENP3 levels recover following reoxygenation after OGD allowing deSUMOylation of Drp1, which facilitates Drp1 localization at mitochondria and promotes fragmentation and cytochrome c release. RNAi knockdown of SENP3 protects cells from reoxygenation-induced cell death via a mechanism that requires Drp1 SUMOylation. Thus, we identify a novel adaptive pathway to extreme cell stress in which dynamic changes in SENP3 stability and regulation of Drp1 SUMOylation are crucial determinants of cell fate.